Announcements Trials
Browse Landscape

Phase

Phase NA 28Phase 2 15Phase 3 5Phase 1 4Phase EARLY_PHASE1 3Phase 2/3 3Phase 1/2 3

Status

Completed 2Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Polyps 2Hyperplasia 2Carcinoma 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Endoscopy × Clear all
NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting
498 enrolled
Tumor-Agnostic

Carcinoma

NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed
58 enrolled 12 charts
Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡